Skip to main content

New Experimental Gel May Help Prevent Hair Loss During Chemotherapy, Early Research Finds

By I. Edwards HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 4, 2025.

via HealthDay

THURSDAY, Sept. 4, 2025 — A new shampoo-like gel developed by researchers at Michigan State University could help protect cancer patients from a common and dreaded side effect of chemotherapy: Hair loss.

The gel, which has been tested in animal models, is designed to be applied to the scalp before treatment and left on while chemotherapy drugs circulate through the body.

“This unmet need of chemotherapy-induced alopecia appealed to me because it is adjacent to the typical needs in medicine such as better treatments and earlier, more accurate diagnostics for cancer,” lead researcher Bryan Smith said in a news release. Smith, an associate professor of engineering, is part of MSU’s Institute for Quantitative Health Science and Engineering.

Smith said he began focusing on the issue after interviewing cancer doctors and former patients about hair loss.

"Once I understood, it became clear to me that better solutions are very important to many cancer patients’ quality of life," he explained.

The gel is a water-based gel designed to deliver drugs to the scalp and protect hair follicles. It contains lidocaine and adrenalone, which work by restricting blood flow to the scalp.

This helps prevent chemo drugs from reaching the hair follicles, thereby reducing damage and hair loss.

The gel also changes with temperature. At body temperature, it stays thicker and clings to the scalp. When at cooler temperatures, it becomes thinner and easier to wash away.

The research, publishing in the January 2026 issue of the journal Biomaterials Advances, is still in the early stages and has not yet been tested in humans.

“The research has the potential to help many people,” Smith said. “All the individual components are well-established, safe materials, but we can’t move forward with follow-up studies and clinical trials on humans without the support of substantial funding.”

Sources

  • Michigan State University, news release, Sept. 2, 2025

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Fear Of Hair Loss Might Cause Some To Reject Cancer Treatment

WEDNESDAY, Aug. 6, 2025 — Needless fear of hair loss and brittle, discolored nails caused by cancer treatment might lead many patients to avoid or delay life-saving...

Your Loving Partner Can Protect You From Chemo Brain

FRIDAY, May 2, 2025 — A cancer patient’s bond with their partner can be a key factor in helping them ward off chemotherapy-related “brain fog,” a new study...

FDA Warns of Unapproved Hair-Loss Product Linked to Side Effects

THURSDAY, April 24, 2025 — A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left them battling sexual...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.